Omeprazol Cinfamed may be available in the countries listed below.
Ingredient matches for Omeprazol Cinfamed
Omeprazole is reported as an ingredient of Omeprazol Cinfamed in the following countries:
- Spain
International Drug Name Search
Omeprazol Cinfamed may be available in the countries listed below.
Omeprazole is reported as an ingredient of Omeprazol Cinfamed in the following countries:
International Drug Name Search
Mirtazapin Smelt may be available in the countries listed below.
Mirtazapine is reported as an ingredient of Mirtazapin Smelt in the following countries:
International Drug Name Search
Insulin Hypurin Porcine Neutral may be available in the countries listed below.
Insulin Injection, Soluble porcine (a derivative of Insulin Injection, Soluble) is reported as an ingredient of Insulin Hypurin Porcine Neutral in the following countries:
International Drug Name Search
met-FOR-min hye-droe-KLOR-ide, roe-zi-GLI-ta-zone MAL-ee-ate
May cause or worsen congestive heart failure, is not recommended in patients with symptomatic heart failure, and is contraindicated in patients with established NYHA Class III or IV heart failure. Monitor patients for signs and symptoms of heart failure after initiation or dose increases and if heart failure occurs, consider dose reducing or discontinuing rosiglitazone maleate and manage according to current standards of care. A meta-analysis of 52 clinical trials (mean duration 6 months; 16,995 total patients), most of which compared rosiglitazone to placebo, showed rosiglitazone to be associated with a statistically significant increased risk of myocardial infarction. Because of the potential increased risk of myocardial infarction, rosiglitazone maleate/metformin hydrochloride is available only through a restricted distribution program called the AVANDIA-Rosiglitazone Medicines Access Program. Both prescribers and patients need to enroll in the program. To enroll, call 1-800-AVANDIA or visit www.AVANDIA.com .Lactic acidosis can occur due to metformin accumulation during treatment with rosiglitazone maleate/metformin hydrochloride. The risk of lactic acidosis increases with conditions such as sepsis, dehydration, excess alcohol intake, hepatic insufficiency, renal impairment, and acute congestive heart failure. Symptoms include malaise, myalgias, respiratory distress, increasing somnolence, and nonspecific abdominal distress. Laboratory abnormalities include low pH, increased anion gap, and elevated blood lactate. Discontinue therapy immediately and institute supportive measures promptly for suspected lactic acidosis .
In the U.S.
Available Dosage Forms:
Therapeutic Class: Hypoglycemic
Chemical Class: Metformin
Rosiglitazone and metformin combination is used to treat a type of diabetes mellitus called type 2 diabetes. It is used together with a proper diet and exercise to help control blood sugar levels.
Rosiglitazone helps your body use insulin better. Metformin reduces the absorption of sugar from the stomach, reduces the release of stored sugar from the liver, and helps your body use sugar better.
metformin and rosiglitazone is only available through a restricted access program. Doctors who are enrolled in the program can write a prescription for metformin and rosiglitazone.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For metformin and rosiglitazone, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to metformin and rosiglitazone or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of rosiglitazone and metformin combination in the pediatric population. Safety and efficacy have not been established.
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of rosiglitazone and metformin combination in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving rosiglitazone and metformin combination.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking metformin and rosiglitazone, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using metformin and rosiglitazone with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
Using metformin and rosiglitazone with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Using metformin and rosiglitazone with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
The presence of other medical problems may affect the use of metformin and rosiglitazone. Make sure you tell your doctor if you have any other medical problems, especially:
Take metformin and rosiglitazone only as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered.
Carefully follow the special diet your doctor gave you. This is the most important part of controlling your diabetes and will help the medicine work properly. Also, exercise regularly and test for sugar in your blood or urine as directed.
metformin and rosiglitazone is only available through a restricted access program. Both you and your doctor must enroll in this program. You might have to sign a consent form in order to receive metformin and rosiglitazone and your doctor will closely monitor your progress while you are taking metformin and rosiglitazone. Talk to your doctor if you have questions about this.
metformin and rosiglitazone should come with a Medication Guide. It is very important that you read and understand this information. Be sure to ask your doctor about anything you do not understand.
metformin and rosiglitazone should be taken with meals to help reduce the unwanted stomach effects that may occur during the first few weeks.
The dose of metformin and rosiglitazone will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of metformin and rosiglitazone. If your dose is different, do not change it unless your doctor tells you to do so.
The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.
If you miss a dose of metformin and rosiglitazone, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.
Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.
Keep out of the reach of children.
Do not keep outdated medicine or medicine no longer needed.
Ask your healthcare professional how you should dispose of any medicine you do not use.
It is very important that your doctor check your progress at regular visits to make sure that metformin and rosiglitazone is working properly. Blood and urine tests may be needed to check for unwanted effects.
Call your doctor right away if you have chest pain or discomfort; nausea; pain or discomfort in the arms, jaw, back, or neck; shortness of breath; sweating; or vomiting. These may be symptoms of a heart attack.
If you are rapidly gaining weight or having shortness of breath, chest pain or discomfort, extreme tiredness or weakness, irregular breathing, irregular heartbeat, or excessive swelling of the hands, wrist, ankles, or feet, check with your doctor right away. These may be symptoms of a heart problem or edema (fluid retention).
Let your doctor or dentist know you are taking metformin and rosiglitazone. Your doctor may advise you to stop taking metformin and rosiglitazone before you have major surgery or diagnostic tests, especially tests that use a contrast dye.
Under certain conditions, too much metformin can cause a serious condition called lactic acidosis. The symptoms of lactic acidosis are severe and appear quickly. Lactic acidosis usually occurs when other serious health problems are present, such as a heart attack or kidney failure. The symptoms of lactic acidosis include: abdominal or stomach discomfort; decreased appetite; diarrhea; fast or shallow breathing; a general feeling of discomfort; muscle pain or cramping; and unusual sleepiness, tiredness, or weakness. If you have more than one of these symptoms together, you should get immediate emergency medical help.
If you have abdominal or stomach pain; dark urine; a loss of appetite; nausea or vomiting; unusual tiredness or weakness; or yellow eyes or skin, check with your doctor right away. These may be symptoms of a serious liver problem.
Check with your doctor right away if blurred vision, difficulty in reading, or any other change in vision occurs while you are taking metformin and rosiglitazone. Your doctor may want you to have your eyes checked by an ophthalmologist (eye doctor).
Certain women may be at an increased risk for pregnancy while taking metformin and rosiglitazone. If you had problems ovulating and had irregular periods in the past, metformin and rosiglitazone may cause you to ovulate. This could increase your chance of becoming pregnant. If you are a woman of childbearing potential, you should discuss birth control options with your doctor.
metformin and rosiglitazone may increase the risk for bone fractures in women. Ask your doctor about ways to keep your bones strong to help prevent fractures.
Make sure any doctor or dentist who treats you knows that you are using metformin and rosiglitazone. metformin and rosiglitazone may affect the results of certain medical tests.
It is very important to follow carefully any instructions from your doctor about:
metformin and rosiglitazone can cause hypoglycemia (low blood sugar). Low blood sugar can also occur if you delay or miss a meal or snack, exercise more than usual, drink alcohol, or cannot eat because of nausea or vomiting. The symptoms of low blood sugar must be treated before they lead to unconsciousness (passing out). Different people feel different symptoms of low blood sugar. It is important that you learn which symptoms of low blood sugar you usually have so that you can treat it quickly.
Hyperglycemia (high blood sugar) may occur if you do not take enough or skip a dose of your medicine, overeat or do not follow your meal plan, have a fever or infection, or do not exercise as much as usual.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
Lidesthesin may be available in the countries listed below.
Lidocaine hydrochloride (a derivative of Lidocaine) is reported as an ingredient of Lidesthesin in the following countries:
International Drug Name Search
Cleanfive may be available in the countries listed below.
Clinofibrate is reported as an ingredient of Cleanfive in the following countries:
International Drug Name Search
Active Ingredients (in each tablet) Chlorcyclizine Hydrochloride 25 mg Phenylephrine Hydrochloride 10 mg
Antihistamine Nasal Decongestant
Keep out of reach of children.
Uses
Temporarily relieves these symptoms due to the common cold, hay fever (allergic rhinitis) or other upper respiratory allergies:
runny nose sneezing itching of the nose or throat itchy, watery eyes nasal congestion reduces swelling of nasal passages
Warnings
Do not exceed recommended dosage.
Do not use this product if you are now taking a prescription monamine oxidase inhibitor (MAOI)(certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
Ask a doctor before use if you have a breathing problem such as emphysema or chronic bronchitis glaucoma difficulty in urination due to enlargement of the prostate gland heart disease high blood pressure thyroid disease diabetes
Ask a doctor or pharmacist before use if you are taking sedatives, or tranquilizers.
When using this product excitability may occur, especially in children may cause drowsiness avoid alcoholic drinks alcohol, sedatives, and tranquilizers may increase the drowsiness effect be careful when driving a motor vehicle or operating machinery
Stop use and ask a doctor if nervousness, dizziness, or sleeplessness occur symptoms do not improve within 7 days or are accompanied by fever new symptoms occur
In case of overdose, get medical help or contact a Poison Control Center right away.
If pregnant or breast-feeding, ask a health professional before use.
Directions
Do not exceed 3 doses in a 24 hour period.
Adults and children 12 years of age and over: 1 tablet every 6-8 hours, not to exceed 3 tablets in 24 hours.
Children 6 to under 12 years of age: 1/2 tablet every 6-8 hours, not to exceed 1-1/2 tablets in 24 hours.
Children under 6 years of age: Consult a doctor.
Inactive ingredients Magnesium Stearate, Microcrystalline Cellulose, Sodium Starch Glycolate
Store at 59 - 86 degrees F (15 - 30 degrees C)
Questions? Comments?
Call 1-864-286-8229
NDC 16477-160-01 Dallergy Tablets New Improved formula Antihistamine Nasal Decongestant For Professional Use
Each tablet contains: Chlorcyclizine HCI... 25 mg Phenylephrine HCI... 10 mg Laser 100 Tablets Rev 9/11 Lot No: Exp. Date:
For full prescribing information, see the product foldout. Store at 59 - 86 degrees F (15 - 30 degrees C)
Tamper-evident by foil seal under cap. Do not use if foil seal is broken or missing.
This bottle is not to be dispensed to the consumer.
Dispense in a tight, light-resistant container as defined in the USP/NF with a child-resistant closure.
The labeling for this product includes professional labeling which is not intended for use by the general public.
WARNING: KEEP THIS AND ALL DRUGS OUT OF THE REACH OF CHILDREN.
IN CASE OF OVERDOSE, GET MEDICAL HELP OR CONTACT A POISON CONTROL CENTER RIGHT AWAY.
LASER Manufactures for Laser Pharmaceuticals, LLC Greenville, SC 29615
| DALLERGY chlorcyclizine hydrochloride tablet | ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| ||||||||||||||||||||
| Marketing Information | |||
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part341 | 11/01/2011 | |
| Labeler - Laser Pharmaceuticals, LLC (614417132) |
| Registrant - Laser Pharmaceuticals, LLC (614417132) |
| Establishment | |||
| Name | Address | ID/FEI | Operations |
| TG United Pharmaceuticals, Inc. | 963714766 | manufacture | |